Nemaline Rod/Cap Myopathy Due to Novel Homozygous MYPN Mutations: The First Report from South Asia and Comprehensive Literature Review
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose Pathogenic variants in the myopalladin gene (MYPN) are known to cause mildly progressive nemaline/cap myopathy. Only nine cases have been reported in the English literature. Methods A detailed evaluation was conducted of the clinical, muscle magnetic resonance imaging (MRI), and genetic findings of two unrelated adults with MYPN-related cap myopathy. Genetic analysis was performed using whole-exome sequencing. MRI was performed on a 1.5-T device in patient 1. Results Two unrelated adults born to consanguineous parents, a 28-year-old male and a 23-year-old female, were diagnosed with pathogenic variants in MYPN that cause cap myopathy. Both patients presented with early-onset, insidiously progressive, and minimally disabling proximodistal weakness with mild ptosis, facial weakness, and bulbar symptoms. Patient 1 had a prominent foot drop from the onset. Both patients were followed up at age 30 years, at which point serum creatine kinase concentrations were minimally elevated. There were no cardiac symptoms; electrocardiograms and two-dimensional echocardiograms were normal in both patients. Muscle MRI revealed preferential involvement of the glutei, posterior thigh muscles, and anterior leg muscles. Whole-exome sequencing revealed significant homozygous splicesite variants in both of the probands, affecting intron 10 of MYPN: c.1973+1G>C (patient 1) and c.1974-2A>C (patient 2). Conclusions This study elaborates on two patients with homozygous MYPN pathogenic variants, presenting as slowly progressive congenital myopathy. These patients are only the tenth and eleventh cases reported in the English literature, and the first from South Asia. The clinical phenotype reiterates the mild form of nemaline rod/cap myopathy. A comprehensive literature review is presented.
Abstract
Background and Purpose Pathogenic variants in the myopalladin gene (MYPN) are known to cause mildly progressive nemaline/cap myopathy. Only nine cases have been reported in the English literature. Methods A detailed evaluation was conducted of the clinical, muscle magnetic resonance imaging (MRI), and genetic findings of two unrelated adults with MYPN-related cap myopathy. Genetic analysis was performed using whole-exome sequencing. MRI was performed on a 1.5-T device in patient 1. Results Two unrelated adults born to consanguineous parents, a 28-year-old male and a 23-year-old female, were diagnosed with pathogenic variants in MYPN that cause cap myopathy. Both patients presented with early-onset, insidiously progressive, and minimally disabling proximodistal weakness with mild ptosis, facial weakness, and bulbar symptoms. Patient 1 had a prominent foot drop from the onset. Both patients were followed up at age 30 years, at which point serum creatine kinase concentrations were minimally elevated. There were no cardiac symptoms; electrocardiograms and two-dimensional echocardiograms were normal in both patients. Muscle MRI revealed preferential involvement of the glutei, posterior thigh muscles, and anterior leg muscles. Whole-exome sequencing revealed significant homozygous splicesite variants in both of the probands, affecting intron 10 of MYPN: c.1973+1G>C (patient 1) and c.1974-2A>C (patient 2). Conclusions This study elaborates on two patients with homozygous MYPN pathogenic variants, presenting as slowly progressive congenital myopathy. These patients are only the tenth and eleventh cases reported in the English literature, and the first from South Asia. The clinical phenotype reiterates the mild form of nemaline rod/cap myopathy. A comprehensive literature review is presented.
참고문헌 (17)
- Bang ML, "Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies", J Cell Biol, 153, pp.413~427 (2001)
- Parast MM, "Characterization of palladin, a novel protein localized to stress fibers and cell adhesions", J Cell Biol, 150, pp.643~656 (2000)
- Zhao Y, "Targeted next-generation sequencing of candidate genes reveals novel mutations in patients with dilated cardiomyopathy", Int J Mol Med, 36, pp.1479~1486 (2015)
- Purevjav E, "Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations", Hum Mol Genet, 21, pp.2039~2053 (2012)
- Duboscq-Bidot L, "Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy", Cardiovasc Res, 77, pp.118~125 (2008)
- Meyer T, "Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy", Eur J Hum Genet, 21, pp.294~300 (2013)
- Miyatake S, "Biallelic mutations in MYPN, encoding myopalladin, are associated with childhood-onset, slowly progressive nemaline myopathy", Am J Hum Genet, 100, pp.169~178 (2017)
- Lornage X, "Recessive MYPN mutations cause cap myopathy with occasional nemaline rods", Ann Neurol, 81, pp.467~473 (2017)
- Merlini L, "Congenital myopathy with hanging big toe due to homozygous myopalladin(MYPN)mutation", Skelet Muscle, 9, pp.14~ (2019)
- Mercuri E, "Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy", Neuromuscul Disord, 15, pp.303~310 (2005)
- Stramare R, "MRI in the assessment of muscular pathology : a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies", Radiol Med, 115, pp.585~599 (2010)
- Li H, "Fast and accurate long-read alignment with BurrowsWheeler transform", Bioinformatics, 26, pp.589~595 (2010)
- McKenna A, "The Genome Analysis Toolkit : a MapReduce framework for analyzing next-generation DNA sequencing data", Genome Res, 20, pp.1297~1303 (2010)
- Richards S, "Standards and guidelines for the interpretation of sequence variants : a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)
- Cuisset JM, "‘Cap myopathy’ : case report of a family", Neuromuscul Disord, 16, pp.277~281 (2006)
- Fidzianska A, ""Cap disease" : new congenital myopathy", Neurology, 31, pp.1113~1120 (1981)
- Fidziańska A, ""Cap disease"--a failure in the correct muscle fibre formation", J Neurol Sci, 201, pp.27~31 (2002)